Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci.

Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci.

Item
http://www.wikidata.org/entity/Q34003778
A human monoclonal immunoglobulin M reduces bacteremia and inflammation in a mouse model of systemic pneumococcal infectionA peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in miceImmune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable light chain repertoire.The smart targeting of nanoparticlesHuman monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsisImmune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable heavy chain repertoireStructure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci.Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharidePneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice.Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.New concepts in antibody-mediated immunity.Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.Monoclonal antibodies - a proven and rapidly expanding therapeutic modality for human diseases.Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression.
P2860

Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci.

Item
http://www.wikidata.org/entity/Q34003778
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Production of protective human ...... ith human immunoglobulin loci.
@ast
Production of protective human ...... ith human immunoglobulin loci.
@en
Production of protective human ...... ith human immunoglobulin loci.
@nl
type
label
Production of protective human ...... ith human immunoglobulin loci.
@ast
Production of protective human ...... ith human immunoglobulin loci.
@en
Production of protective human ...... ith human immunoglobulin loci.
@nl
prefLabel
Production of protective human ...... ith human immunoglobulin loci.
@ast
Production of protective human ...... ith human immunoglobulin loci.
@en
Production of protective human ...... ith human immunoglobulin loci.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Production of protective human ...... ith human immunoglobulin loci.
@en
P2093
P2860
P304
P31
P356
10.1128/IAI.68.4.1820-1826.2000
P407
P433
P478
P577
P5875
P698
P921
P932